Phase 1a is being completed so they start the recruitment of phase 2 here in Australia for Stroke and Cardio protection during stroke.
At the same time they are recruiting for stroke and Cardio protection for phase 2 in Australia they would have completed the 3 month phase 1b trial for TBI indication and get their IND submitted and approved at the same time phase 1b results are completed to start phase 2 TBI in the USA in 2026
But a genius like your self understands what’s happening right? Like I said many times Zecs your a troll and won’t reply to your donkey posts anymore. Only drug in the world to treat all 3 indications of stroke and secondary TBI.
Thanks Zecs but this will become north of 100 million market cap and a multi billion dollar company on a given phase 2 because it’s already proven that calcium influx inhibition treats TBI and stroke but always needed the length of treatment with no side effects and we have that now with this drug in it’s own drug class
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)